Publications by authors named "R Patacchini"

Claim this Profile
C
Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder.
Cataldo Martucci, Andrew Dennis Allen, Nadia Moretto, Valentina Bagnacani, Alessandro Fioni, Riccardo Patacchini

Front Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.
Laura Carzaniga, Ian D Linney, Andrea Rizzi, Wolfgang Schmidt, Christopher K Knight, Riccardo Patacchini

J Med Chem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder.
Cataldo Martucci, Andrew Dennis Allen, Nadia Moretto, Valentina Bagnacani, Alessandro Fioni, Riccardo Patacchini

Front Pharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of M Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD.
Andrea Rizzi, Gabriele Amari, Fausto Pivetti, Maurizio Delcanale, Francesco Amadei, Riccardo Patacchini

J Med Chem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuronal and non-neuronal TRPA1 as therapeutic targets for pain and headache relief.
Luigi F Iannone, Romina Nassini, Riccardo Patacchini, Pierangelo Geppetti, Francesco De Logu

Temperature (Austin)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis